S
ONE TO WATCH:
Ameet Mallik, Brand Director, Tekturna, Novartis
Many pharma leaders start as sales reps. Mallik, 35, did it the other way around—he entered Novartis as a Basel-based VP after a five-year stint at McKinsey. So when it was time to move to the US, he spent six months carrying the bag. "Novartis does a great job of talent development. That's one reason I came here—to broaden my operational skills so that I can move into a larger GM role."
Beyond the Birthrate: The Societal Costs of Maternal Mortality
September 6th 2024Head of Medical Affairs and Outcomes Research at Organon, Charlotte Owens, MD, FACOG, discusses the most critical changes needed to close the gaps in R&D for maternal health solutions and how feasible they are to make.
Efsitora Demonstrates Non-Inferiority vs. Insulin Glargine, Degludec for Type 2 Diabetes
September 5th 2024Results from the QWINT-1 and QWINT-3 trials found that insulin-naïve patients achieved similar reductions in A1C levels using once-weekly efsitora compared to daily insulin glargine and degludec.